ENESDENewsletter →
Shotlee
Get the app
💊Oral GLP-1🏷️Brand Name🏢Eli Lilly

Foundayo Tracker App

Track Your Foundayo (Orforglipron) Protocol

Foundayo (orforglipron) is Eli Lilly's oral GLP-1 pill with up to 14.7% weight loss in Phase 2 trials. Shotlee is the free app to track your complete Foundayo protocol — daily doses, side effects, weight, and labs.

Download on theApp Store
Get it onGoogle Play
25,000+Active Users
4.8★App Rating
FreeAlways Free
Active Users
25,000+
App Rating
4.8★
Always Free
Free
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
⌄
ACTIVE MEDICATIONS
TirzepatideB12
TIRZEPATIDE
🔥 14
2
days away
Thursday · 7.5mg
⌄
Medication Supply
Tirzepatide
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
TirzepatideRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
⌄
ACTIVE MEDICATIONS
TirzepatideB12
TIRZEPATIDE
🔥 14
2
days away
Thursday · 7.5mg
⌄
Medication Supply
Tirzepatide
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
TirzepatideRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01BACKGROUND

What Is Foundayo?

Foundayo (orforglipron) is Eli Lilly's oral non-peptide GLP-1 receptor agonist — a once-daily weight loss pill that doesn't require injections or fasting. Phase 3 ATTAIN trials have shown meaningful weight loss, and FDA submission is underway.

Shotlee tracks every aspect of your Foundayo protocol: daily pill intake, doses, side effects, weight changes, measurements, and lab results. Whether you're starting Foundayo or optimizing your dose, clean data helps you and your prescriber make better decisions.

02WHAT TO TRACK

What to Track in Shotlee

Build a complete Foundayo protocol record from day one.

01
💊
Daily Dose Log
Record every pill — date, dose amount (mg), and time taken. Daily reminders keep you consistent.
02
⚖️
Weekly Weight
Track body weight consistently to see your response curve over time.
03
🤢
Side Effects
Log any side effects with severity ratings to share with your prescriber.
04
🩸
Lab Results
Save blood work and biomarkers (HbA1c, fasting glucose, lipids) from clinic visits.
05
📐
Measurements
Waist, hip, and other body measurements reveal changes the scale may miss.
06
😴
Notes & Mood
Daily notes on energy, appetite, sleep, nausea, and overall wellbeing.
03MECHANICS

How to Track Your Foundayo Protocol

1
Set a baseline: log your starting weight, measurements, and any available labs before your first dose
2
Record every daily dose: date, amount (mg), time taken, and any immediate reactions
3
Log weekly weight at the same time and conditions to track your trend accurately
4
Note side effects with severity so your prescriber can adjust your titration schedule
5
Add lab results from each clinic visit to measure biomarker improvements over time
04KEY NUMBERS

Foundayo Key Facts

📈
Category
−0
Non-peptide small molecule (Eli Lilly)
💪
Administration
0Once-Daily Pill
No injection, no fasting required
🏆
Dose Range
0-45 mg/day
Gradual titration from 3 mg to 36-45 mg
05FAQ

Protocol FAQs

Foundayo is the brand name for orforglipron, a once-daily oral non-peptide GLP-1 receptor agonist from Eli Lilly. It's a pill — no injections, no fasting requirements. Phase 3 trials show meaningful weight loss.

Open Shotlee, select Foundayo (orforglipron), and log your daily pill dose. Track weight, side effects, and labs alongside. Daily reminders keep you consistent.

Yes — Foundayo tracking is completely free forever. Premium AI features are available optionally.

Open the Shotlee app, navigate to the dose logging screen, select Foundayo as your medication, and enter the dose amount and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts.

Track gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider.

Most patients notice appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule. Track your weekly weight in Shotlee to visualize your personal response curve.

Free · Always

Track Your Foundayo Protocol in Shotlee

Free dose logs, side effect tracking, weight trends, and lab results — all in one app.

Download on theApp Store
Get it onGoogle Play

📚References & sources

🔗Keep exploring

Foundayo Guide
→
Foundayo vs Wegovy
→
All Trackers
→
GLP-1 Tracker
→
Start tracking